First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT)

CUSIP: 33733E203

Q4 2015 13F Holders as of 31 Dec 2015

Type / Class
Equity / First Trust NYSE(R) Arca(R) Biotechnology Index Fund
Shares outstanding
11,300,576
Total 13F shares
21,779,226
Share change
+1,431,913
Total reported value
$2,459,415,016
Put/Call ratio
19%
Price per share
$113.02
Number of holders
127
Value change
+$164,656,445
Number of buys
64
Number of sells
60

Quarterly Holders Quick Answers

What is CUSIP 33733E203?
CUSIP 33733E203 identifies FBT - First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) as of Q4 2015

As of 31 Dec 2015, First Trust Exchange-Traded Fund - First Trust NYSE(R) Arca(R) Biotechnology Index Fund (FBT) was held by 127 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,779,226 shares. The largest 10 holders included FIRST TRUST ADVISORS LP, MORGAN STANLEY, WELLS FARGO & COMPANY/MN, UBS Group AG, BANK OF AMERICA CORP /DE/, LPL Financial LLC, RAYMOND JAMES & ASSOCIATES, Raymond James Financial Services Advisors, Inc., Transamerica Financial Advisors, Inc., and MetLife Securities, Inc. This page lists 127 institutional shareholders reporting positions in this security for the Q4 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.